Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064173%3A_____%2F24%3A43925980" target="_blank" >RIV/00064173:_____/24:43925980 - isvavai.cz</a>
Alternative codes found
RIV/00023001:_____/24:00084599 RIV/00216224:14110/24:00135367 RIV/00216208:11120/24:43925980 RIV/00216208:11140/24:10467143 and 7 more
Result on the web
<a href="https://doi.org/10.1016/j.hjc.2023.08.009" target="_blank" >https://doi.org/10.1016/j.hjc.2023.08.009</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.hjc.2023.08.009" target="_blank" >10.1016/j.hjc.2023.08.009</a>
Alternative languages
Result language
angličtina
Original language name
Outcomes of patients with myocardial infarction and cardiogenic shock treated with culprit vessel-only versus multivessel primary PCI
Original language description
INTRODUCTION AND OBJECTIVES: Multivessel primary percutaneous coronary intervention (pPCI) is still often used in patients with ST-elevation myocardial infarction (STEMI) and cardiogenic shock (CS). The study aimed to compare the characteristics and prognosis of patients with CS-STEMI and multivessel coronary disease (MVD) treated with culprit vessel-only pPCI or multivessel pPCI during the initial procedure. MATERIAL AND METHODS: From 2016 to 2020, 23,703 primary PCI patients with STEMI were included in a national all-comers registry of cardiovascular interventions. From them, 1,213 (5.1%) patients had cardiogenic shock and MVD at admission to the hospital. Initially, 921 (75.9%) patients were treated with CV-pPCI and 292 (24.1%) with MV-pPCI. RESULTS: Patients with 3-vessel disease and left main disease had a higher probability of being treated with MV-pPCI than patients with 2-vessel disease and patients without left main disease (28.5% vs. 18.6%; p < 0.001 and 37.7% vs. 20.6%; p < 0.001). Intra-aortic balloon pump, extracorporeal membrane oxygenation (ECMO), and other mechanical circulatory support systems were more often used in patients with MV-pPCI. 30-day and 1-year all-cause mortality rates were similar in the CV-pPCI and MV-pPCI groups (Odds ratio, 1.01; 95% CI 0.77 to 1.32; p = 0.937 and 1.1; 95% CI 0.84 to 1.44; p = 0.477). The presence of 3-vessel disease and the use of ECMO were the strongest adjusted predictors of 30-day and 1-year mortality. CONCLUSIONS: Our data from an extensive all-comers registry suggests that selective use of MV-pPCI does not increase the all-cause mortality rate in patients with CS-STEMI and MVD compared to CV-pPCI.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Hellenic Journal of Cardiology
ISSN
1109-9666
e-ISSN
2241-5955
Volume of the periodical
76
Issue of the periodical within the volume
March-April
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
10
Pages from-to
1-10
UT code for WoS article
001227067900001
EID of the result in the Scopus database
2-s2.0-85170086758